The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBanco Santander Regulatory News (BNC)

Share Price Information for Banco Santander (BNC)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 383.50
Bid: 388.00
Ask: 390.00
Change: -4.50 (-1.16%)
Spread: 2.00 (0.515%)
Open: 392.50
High: 393.00
Low: 383.50
Prev. Close: 388.00
BNC Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Results application proposal & Comm. from Auditor

21 Sep 2020 17:56

RNS Number : 6420Z
Banco Santander S.A.
21 September 2020
 

 

 

 

 

Banco Santander, S.A. (the "Bank" or "Santander"), in accordance with the provisions of the Spanish capital markets regulations, announces:

 

OTHER RELEVANT INFORMATION

 

On 2 April 2020, following the recommendation made by the European Central Bank on 27 March 2020 to all European banks under its supervision to preserve capital by cancelling the payment of dividends against 2019 and 2020 results, Santander announced its decision to withdraw the proposal under Item Two (Application of results obtained during financial year 2019) from the agenda of the ordinary general shareholders' meeting of the Bank to be held on 3 April 2020 on second call.

 

Today, as announced as inside information in a disclosure sent to the Spanish National Securities Commission (CNMV), the board of directors of Santander has resolved to call the ordinary general shareholders' meeting of the Bank on 26 and 27 October, on first and second call, respectively, and submitted a new proposal for the application of results obtained during financial year 2019 to that general meeting.

 

Today's disclosure also includes the rest of the items on the general shareholders' meeting agenda.

 

In accordance with Royal Decree-Law 8/2020 of 17 March, regarding urgent extraordinary measures to address the economic and social impact of COVID-19 (Art. 41.3) (Real Decreto- ley 8/2020, de 17 de marzo, de medidas urgentes extraordinarias para hacer frente al impacto económico y social del COVID-19 (Art. 41.3)), the Bank hereby attaches:

 

- The proposal stated by the board of directors for item one on the agenda of the aforementioned meeting (Application of results obtained during financial year 2019), as well as the justification for it.http://www.rns-pdf.londonstockexchange.com/rns/6420Z_1-2020-9-21.pdf

 

- The communication from the Bank´s auditor in which it is confirmed that the auditor would have not changed its audit opinion if it had known the new application of results proposal when its audit reports on the individual and consolidated 2019 Financial Reports were signed.http://www.rns-pdf.londonstockexchange.com/rns/6420Z_2-2020-9-21.pdf

 

 

Boadilla del Monte (Madrid), 21 September 2020

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCEAKNFASDEEFA
Date   Source Headline
30th Mar 20223:00 pmRNSForm 8.3 - Meggitt Plc
25th Mar 20222:29 pmRNSForm 8.3 - Meggitt plc
25th Mar 20222:27 pmRNSForm 8.3 - Clinigen Group plc
25th Mar 202212:51 pmRNSForm 8.3 - Ultra Electronics Holdings plc
24th Mar 202212:10 pmRNSBuyback programme: transactions 5 - 23 March
15th Mar 202212:40 pmRNSForm 8.3 - Meggitt plc
14th Mar 202211:51 amRNSCommencement of a program to repurchase own shares
9th Mar 202210:04 amRNSForm 8.3 - Meggitt Plc
3rd Mar 202211:58 amRNSForm 8.3 - Spectris plc
3rd Mar 202211:53 amRNSForm 8.3 - Oxford Instruments plc
1st Mar 20224:18 pmRNSOptional early redemption ISIN XS1602466424
28th Feb 202212:22 pmRNSDirector/PDMR Shareholding
28th Feb 20227:00 amRNSNotice of AGM
25th Feb 202211:33 amRNSForm 8.3 - Ultra Electronics Holdings plc
24th Feb 20225:35 pmRNSNotice of AGM
24th Feb 20222:49 pmRNSFurther re dividend declaration
24th Feb 20222:34 pmRNSDividend Declaration
18th Feb 202211:04 amRNSForm 8.3 - Meggitt plc
18th Feb 202210:55 amRNSForm 8.3 - Ultra Electronics Holdings plc
18th Feb 202210:47 amRNSForm 8.3 - Sanne Group plc
17th Feb 202210:54 amRNSForm 8.3 - Meggitt Plc
17th Feb 202210:49 amRNSForm 8.3 - Avast Plc
17th Feb 20227:00 amRNSDirector/PDMR Shareholding
17th Feb 20227:00 amRNSDirector/PDMR Shareholding
17th Feb 20227:00 amRNSDirector/PDMR Shareholding
17th Feb 20227:00 amRNSDirector/PDMR Shareholding
17th Feb 20227:00 amRNSDirector/PDMR Shareholding
17th Feb 20227:00 amRNSDirector/PDMR Shareholding
17th Feb 20227:00 amRNSDirector/PDMR Shareholding
17th Feb 20227:00 amRNSDirector/PDMR Shareholding
17th Feb 20227:00 amRNSDirector/PDMR Shareholding
17th Feb 20227:00 amRNSDirector/PDMR Shareholding
17th Feb 20227:00 amRNSDirector/PDMR Shareholding
17th Feb 20227:00 amRNSDirector/PDMR Shareholding
17th Feb 20227:00 amRNSDirector/PDMR Shareholding
17th Feb 20227:00 amRNSDirector/PDMR Shareholding
17th Feb 20227:00 amRNSDirector/PDMR Shareholding
17th Feb 20227:00 amRNSDirector/PDMR Shareholding
17th Feb 20227:00 amRNSDirector/PDMR Shareholding
16th Feb 20223:20 pmRNSForm 8.3 - Meggitt Plc
16th Feb 20223:18 pmRNSForm 8.3 - Avast Plc
15th Feb 20229:07 amRNSForm 8.3 - Sanne Group plc
10th Feb 202211:37 amRNSForm 8.3 - Avast Plc
7th Feb 20224:43 pmRNSDirector/PDMR Shareholding
3rd Feb 20222:41 pmRNSSREP Capital Requirements 2022
2nd Feb 20228:25 amRNSForm 8.3 - Avast plc
2nd Feb 20227:00 amRNS2021 results report & analyst presentation
2nd Feb 20227:00 amRNS2021 Results - Press release
1st Feb 20223:03 pmRNSNotice of 2021 Results
1st Feb 20229:22 amRNSForm 8.3 - Avast Plc

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.